Financials
- Market Capitalization 460.54 M
- Employee 88
- Founded 1994
- CEO Craig A Tooman
- Website www.silence-therapeutics.com
- Headquarter United Kingdom
- FIGI BBG00WVTHPN2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.65
Rapporto prezzo/fatturato
1 541.15
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2963 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.56 USD | -3.11% | -20.00% | -6.02% | -25.00% | 471.21 M USD | ||
| 2970 | RZLT Rezolute, Inc. - Common Stock | 4.83 USD | +1.90% | -1.43% | +13.38% | -9.21% | 465.09 M USD | ||
| 2978 | OVID Ovid Therapeutics Inc. - Common Stock | 2.46 USD | +1.23% | -8.21% | +8.37% | +515.00% | 459.13 M USD | ||
| 2989 | PRTA Prothena Corporation plc - Ordinary Shares | 8.64 USD | -2.15% | -10.56% | -1.48% | +34.16% | 452.33 M USD |